Bruce Power and AREVA NP expand agreement for commercialization of radioisotope production

Bruce Power and AREVA NP signed a memorandum of understanding (MOU) on 08/08/2017 to further explore opportunities to commercialize radioisotope production capabilities at the Bruce nuclear facility.

Developing on-line radioisotope production capabilities at the Bruce facility will allow Bruce Power to produce shorter half-life radioisotopes (such as molybdenum-99, lutetium-177 and iridium-192) with a system that inserts and removes targets with little impact on the normal operation of the nuclear reactors. The process will use AREVA NP's patent-pending method of producing radioisotopes using a heavy water nuclear power plant.

Under this agreement, AREVA NP will design and supply the hardware to be installed in the existing units to add the on-line radioisotope production capability. Both Bruce Power and AREVA NP work with industry partners to process and manage the delivery of irradiated radioisotopes to end users.

This MOU builds on an agreement Bruce Power and AREVA NP signed in December 2014 to evaluate the feasibility of developing on-line radioisotope production capabilities at the Bruce facility.

To read more please visit: https://www.dotmed.com/news/story/38565.html

Source: DOTmed.com